CBER to Host Workshop on Patient Engagement and Regenerative Medicine

April 07, 2021

The Office of Tissues and Advanced Therapies within the Center for Biologics Evaluation and Research (CBER) will host a patient engagement workshop next month to explore ways in which patients and their advocates can work with the Food and Drug Administration to help advance regenerative medicine. 

The workshop will address how patients can engage with and provide input to FDA, as well as how stakeholder organizations can share regenerative medicine research activities with the agency. Event speakers will also share case studies from previous patient engagement experiences and discuss ways to enhance interactions between patients, their advocates and FDA to further regenerative medicine.

This complimentary virtual event will take place from 11 a.m. to 3 p.m. ET on Thursday, May 6. Registration information is available online